Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/30/2014 | US20140322754 Method for highly expressing recombinant protein of engineering bacteria and use thereof |
10/30/2014 | US20140322752 Refolding transforming growth factor beta family proteins |
10/30/2014 | US20140322730 Botulinum Neurotoxin E Receptors and Uses Thereof |
10/30/2014 | US20140322725 Sensors and assays for ubiquitin or ubiquitin-like proteins |
10/30/2014 | US20140322718 Competence stimulating peptide |
10/30/2014 | US20140322301 Mucin antigen vaccine |
10/30/2014 | US20140322279 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof |
10/30/2014 | US20140322274 Therapeutic Agents |
10/30/2014 | US20140322269 Engineered outer domain (eod) of hiv gp120 and mutants thereof |
10/30/2014 | US20140322257 Fusion proteins representing different ns: proposal for a vaccine against allergy to mites |
10/30/2014 | US20140322254 Polypeptide adjuvant |
10/30/2014 | US20140322216 Glypican-3-specific antibody and uses thereof |
10/30/2014 | US20140322212 Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells |
10/30/2014 | US20140322205 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
10/30/2014 | US20140322192 Proteoglycan degrading mutants for treatment of cns |
10/30/2014 | US20140322132 Fragments of p97 and uses thereof |
10/28/2014 | US8871999 Protection against herbivores |
10/28/2014 | US8871931 Di-O-methylcoelenteramide and analogs thereof for production of coelenteramide and analogs thereof |
10/28/2014 | US8871915 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
10/28/2014 | US8871906 Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes |
10/28/2014 | US8871905 Modification of CXCR4 using engineered zinc finger proteins |
10/28/2014 | US8871900 Fibroblast growth factor (FGF) analogs and uses thereof |
10/28/2014 | US8871899 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
10/28/2014 | US8871734 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
10/28/2014 | US8871724 Oligopeptidic compounds and uses thereof |
10/28/2014 | US8871723 Glycan modified soluble receptors and binding protein and their use |
10/28/2014 | US8871712 Somatostatin analogue formulations |
10/28/2014 | US8871710 Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein |
10/28/2014 | US8871709 Synthetic chimeric proteins comprising epidermal growth factor and vitronectin |
10/28/2014 | US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles |
10/28/2014 | US8871707 Elastin producing fibroblast formulations and methods of using the same |
10/28/2014 | US8871489 Metabolic evolution of Escherichia coli strains that produce organic acids |
10/28/2014 | US8871468 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
10/28/2014 | US8871466 Method for enhancing the production yield of human papillomavirus L1 protein |
10/28/2014 | US8871223 HSV-1 and HSV-2 vaccines and methods of use thereof |
10/28/2014 | US8871222 Recombinant Flavivirus vaccines |
10/28/2014 | US8871221 Methods of stimulating protective immunity employing Dengue viral antigens |
10/28/2014 | US8871216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases |
10/28/2014 | US8871214 Detoxified Escherichia coli immunogens |
10/28/2014 | US8871213 Prevention, treatment and diagnosis of P. gingivalis infection |
10/28/2014 | US8871212 Amyloid-beta polypeptide vaccine |
10/28/2014 | US8871206 Anti-human folate receptor beta antibodies and methods of use |
10/28/2014 | US8871205 Methods and compositions for the treatment of immune disorders |
10/28/2014 | US8871192 IL-1F8 polypeptides |
10/28/2014 | US8871191 Use of IL-15 preparations to treat lymphopenia |
10/23/2014 | US20140317778 Nucleic acid molecules encoding enzymes that confer disease resistance in jute |
10/23/2014 | US20140316122 Hepatitis b virus vaccines |
10/23/2014 | US20140316116 Methods for screening for binding partners of g-protein coupled receptors |
10/23/2014 | US20140316114 Method for preparing active form of tnfr-fc fusion protein |
10/23/2014 | US20140316109 Activated collagen scaffold materials and their special fused active restoration factors |
10/23/2014 | US20140316106 Integrin-blocking polypeptides and uses thereof |
10/23/2014 | US20140316105 Method for modification of organic molecules |
10/23/2014 | US20140315987 Cholecystokinin b receptor (cckbr) mini-promoters |
10/23/2014 | US20140315984 Methods and Compositions for Treatment of Diabetes and Related Disorders |
10/23/2014 | US20140315825 Anti-cancer compositions containing wnt decoy receptor |
10/23/2014 | US20140315824 Peptide preparations and peptides with antitumour activity |
10/23/2014 | US20140315822 High mast2-affinity polypeptides and uses thereof |
10/23/2014 | US20140315820 High-Potency Botulinum Toxin Formulations |
10/23/2014 | US20140315819 Active small-molecule donkey-hide gelatin mixture and preparation method and application thereof |
10/23/2014 | US20140315817 Variant serum albumin with improved half-life and other properties |
10/23/2014 | US20140315816 Albumin variants |
10/23/2014 | US20140315804 Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof |
10/23/2014 | US20140315802 Derivatisation of Erythropoietin (EPO) |
10/23/2014 | US20140315800 Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide |
10/23/2014 | US20140315798 Chemically and thermodynamically stable insulin analogues and improved methods for their production |
10/23/2014 | US20140315797 Novel N-Terminally Modified Insulin Derivatives |
10/23/2014 | US20140315791 Method of making biologically active alpha-beta peptides |
10/23/2014 | US20140315784 Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein |
10/23/2014 | US20140315746 Compositions and methods for the treatment of prostate carcinoma |
10/23/2014 | US20140315299 Stable proteins |
10/23/2014 | US20140315276 Synthesis of linear and branched polymers of polypeptides through direct conjugation |
10/23/2014 | US20140315253 Activated collagen scaffold materials and their special fused active restoration factors |
10/23/2014 | US20140315231 Quantification of transthyretin and its isoforms |
10/23/2014 | US20140314838 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs for treating contrast-induced nephropathy |
10/23/2014 | US20140314836 Modulation of Midbody Derivatives |
10/23/2014 | US20140314831 Recombinant polypeptides for membrane fusion and uses thereof |
10/23/2014 | US20140314830 Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec) |
10/23/2014 | US20140314816 Stabilized stat3 decoy oligonucleotides and uses therefore |
10/23/2014 | US20140314802 Novel compositions and methods |
10/23/2014 | US20140314801 Vaccines and methods to treat lyme disease in dogs |
10/23/2014 | US20140314797 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
10/23/2014 | US20140314796 Marker for neuromyelitis optica |
10/23/2014 | US20140314772 Anti-c5a binding moieties with high blocking activity |
10/23/2014 | US20140314770 Kidney disease targets and uses thereof |
10/23/2014 | US20140314768 Methods and compositions for treating and diagnosing diseases |
10/23/2014 | US20140314761 Polypeptides having antiviral activity and methods for use thereof |
10/23/2014 | US20140314760 Serine protease molecules and therapies |
10/23/2014 | US20140314759 Isolated nucleotide sequences encoding gdf traps |
10/23/2014 | US20140314712 Fusion protein comprising an interleukin 4 and interleukin |
10/23/2014 | US20140314711 IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE |
10/23/2014 | US20140314709 Il-2 derivatives polypeptides with agonist activity for therapy of cancer and chronic infections |
10/21/2014 | US8865968 Method for down-regulating gene expression in fungi |
10/21/2014 | US8865967 Defensin variants and methods of use |
10/21/2014 | US8865880 Identification of a novel BHD gene |
10/21/2014 | US8865876 Engineered lectin oligomers with antiviral activity |
10/21/2014 | US8865869 Collagen and fibrin microthreads in a discrete thread model of in vitro ACL scaffold regeneration |
10/21/2014 | US8865868 Conjugated proteins with prolonged in vivo efficacy |
10/21/2014 | US8865867 Lectins and uses thereof |
10/21/2014 | US8865866 Diphtheria toxin variant |
10/21/2014 | US8865864 Mutant epidermal growth factor polypeptides with improved biological activity and methods of their making and use |